Severance Hospital, Yonsei University Health System — Seoul

Public research footprint of Severance Hospital, Yonsei University Health System, compiled from the ClinicalTrials.gov public registry.

1,060

Registered studies

484

Active

253

Recruiting now

423

Completed

112

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Non-Small Cell Lung Cancer (NSCLC) · HR Low-Positive/HER2-Negative Breast Neoplasms · Relapsed or Refractory Multiple Myeloma

Recently updated registry entries

NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)
NCT05583617 — A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With… (Recruiting)
NCT06790693 — A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Severance Hospital, Yonsei University Health System?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.